Esophageal Cancer (DBCOND0028460)

Identifiers

Synonyms
Cancer of Esophagus / Oesophageal Cancer / Malignant Neoplasm of Esophagus / Oesophageal neoplasms malignant / Esophageal Cancers / Esophageal Neoplasms Malignant / Esophageal Cancers NOS / Oesophagus Cancer / Cancer Esophagus / Esophagus Cancer / Esophageal cancer / Oesophageal cancer NOS / Esophageal cancer NOS / Malignant neoplasm of esophagus, unspecified / Malignant neoplasm of oesophagus, unspecified / Malignant tumor of esophagus (disorder) / Malignant neoplasm of oesophagus / Malignant neoplasm of esophagus NOS / Malignant neoplasm of oesophagus NOS / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Carcinoma of esophagus (disorder) / Carcinoma of esophagus / Oesophageal carcinoma NOS / Oesophageal carcinoma / Esophageal carcinoma NOS / Esophageal carcinoma

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Docetaxel
A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Irinotecan
A topoisomerase inhibitor used to treat metastatic carcinoma of the colon or rectum and pancreatic adenocarcinoma.
Paclitaxel
A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.
Porfimer sodium
A hematoporphyrin derivative used to treat esophageal cancer, endobronchial cancer, and high grade dysplasia in Barrett's Esophagus.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00318903
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancertreatment2completed
NCT04032353
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule GastroscopyNo drug interventionsscreeningNot Availableunknown_status
NCT03993353
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancertreatment2recruiting
NCT03301493
Genomic Testing and Resulting Medical DecisionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03274349
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial CarcinomaNo drug interventionssupportive_careNot Availableunknown_status
NCT04314349
Radiogenomics in Aerodigestive Tract CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT04258813
Onco-primary Care Networking to Support TEAM-based CareNo drug interventionspreventionNot Availablerecruiting
NCT03719716
Early Support in Primary Care for People Starting Treatment for CancerNo drug interventionssupportive_careNot Availablecompleted
NCT03133286
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)No drug interventionsNot AvailableNot Availablecompleted
NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03102229
Real-time Activity Monitoring to Prevent Admissions During RadioTherapyNo drug interventionssupportive_careNot Availablecompleted
NCT05088304
GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02843750
Study of Inspiratory Muscle Training for Patients Undergoing Esophageal SurgeryNo drug interventionspreventionNot Availablewithdrawn
NCT02017002
Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT04984733
Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancertreatment2recruiting
NCT05830097
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT02530983
Mayo Clinic Upper Digestive Disease SurveyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03108885
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and RecurrenceNo drug interventionsNot AvailableNot Availableterminated
NCT03619317
Impact of Cancer Therapy on Myocardial Function in Patients With Esophagus CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00193817
Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective TrialNo drug interventionstreatment3unknown_status
NCT05179824
Tempus Priority Study: A Pan-tumor Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03032224
Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)No drug interventionsNot AvailableNot Availableunknown_status
NCT05041335
Wet Heparinized Suction for Abdominal CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04886635
Surgery As Needed for Oesophageal Cancer - 2No drug interventionsNot AvailableNot Availablerecruiting
NCT04455282
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1No drug interventionsNot AvailableNot Availablerecruiting
NCT03347162
Muscle Dysfunction in Gastrointestinal or Hepatobiliary CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03541629
Audit of the Spanish EURECCA Esophagogastric Cancer RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT04046601
Impedance Spectroscopy in Esophageal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT03185403
The Hemodynamic Effect Between Two Types of Anesthesia in Esophageal Surgerysupportive_careNot Availablecompleted
NCT06447064
Cancer Loyalty Card Study 2 (CLOCS-2)No drug interventionsNot AvailableNot Availablerecruiting
NCT06277921
Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer SurgeryNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02780921
Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control TrialNo drug interventionstreatment3unknown_status
NCT05035602
Google Location History Following Oesophagectomy and/or GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02774551
Physical Activity Intervention Trial to Mitigate Muscle Loss and Increase Muscle StrengthNo drug interventionstreatmentNot Availableterminated
NCT06364553
Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy StudyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03978377
Cardiopulmonary Toxicity of Thoracic RadiotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00934505
Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01915693
ROCS (Radiotherapy After Oesophageal Cancer Stenting) StudyNo drug interventionstreatment3completed
NCT04001478
Non-invasive Testing for Early oEesophageal Cancer and DysplasiaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05831488
Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02741856
Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalationtreatment2 / 3unknown_status
NCT02382237
Comparison of Tumor Glucose Metabolism Before and After Artificial NutritionNo drug interventionsdiagnosticNot Availablecompleted
NCT03658837
Gastrointestinal Functional Outcome Ivor LewisNo drug interventionsNot AvailableNot Availablecompleted
NCT01726452
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)treatment3completed
NCT04440800
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT06212700
PRIORITY-CONNECT 2 Pilot TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT01657175
Quality of Life After Oesophageal or Gastric Cancer SurgeryNo drug interventionspreventionNot Availablecompleted
NCT05143970
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumorstreatment1recruiting
NCT02465736
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)treatment3active_not_recruiting
NCT05057013
HMBD-001 in Advanced HER3 Positive Solid TumoursNo drug interventionstreatment1 / 2recruiting
NCT03452319
Effects of Increased Physical Activity Before Thoracoabdominal Esophageal SurgeryNo drug interventionspreventionNot Availablecompleted
NCT03958019
Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05540119
Swedish Oesophago-Gastric StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04440124
Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05412758
Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)No drug interventionsdiagnosticNot Availablerecruiting
NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursNo drug interventionstreatment1recruiting
NCT04415463
Esophageal Multisegmented FCSEMS for Malignant StricturesNo drug interventionstreatmentNot Availableterminated
NCT06414122
Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer PatientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03486730
BT1718 in Patients With Advanced Solid Tumours.No drug interventionstreatment1 / 2completed
NCT01179074
Role of Radiotherapy Following Oesophageal Stenting in CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04476082
Nutrition in Gastrointestinal TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT01795976
NY-ESO-1 T Cells in OG Cancertreatment2terminated
NCT06302660
Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer SurvivorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03216694
The Association Between Preoperative CPEX and Postoperative Morbidity Following OesophagectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05685862
Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric ConduitNo drug interventionsNot AvailableNot Availablerecruiting
NCT01843829
A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancertreatment2unknown_status
NCT04508140
Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasistreatment2terminated
NCT01795768
Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumourstreatment2unknown_status
NCT05357846
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)treatment3recruiting
NCT05074914
Unintentional Weight Loss After OesophagectomyNo drug interventionstreatmentNot Availableunknown_status
NCT06422403
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced CancersNo drug interventionstreatment2not_yet_recruiting
NCT04237090
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxelprevention3completed
NCT04791254
Anorexia iN Cancer Patients: ANCHORNo drug interventionsNot AvailableNot Availablerecruiting
NCT00220077
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00359645
Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk PopulationNo drug interventionsprevention3completed
NCT03829345
A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancertreatment2unknown_status
NCT06290505
A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Studytreatment2recruiting
NCT05784597
A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid TumorsNo drug interventionsdiagnostic1recruiting
NCT05233007
Upper GI Serial Tumour BiopsiesNo drug interventionsNot AvailableNot Availablesuspended
NCT04481256
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapYtreatmentNot Availablerecruiting
NCT03653052
Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumabtreatment2active_not_recruiting
NCT05266300
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.No drug interventionsNot AvailableNot Availablecompleted
NCT04484636
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)No drug interventionsotherNot Availablerecruiting
NCT05642819
REVOLUTION Surgery (REVOLUTION Surgery)No drug interventionsNot AvailableNot Availablerecruiting
NCT02526134
Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and RectumNo drug interventionstreatment2completed
NCT04232735
Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)No drug interventionsotherNot Availablerecruiting
NCT03835663
The Bacterial Composition of the Stomach in Reflux DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06169163
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal NeoplasmsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04603339
ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) CancerNo drug interventionstreatmentNot Availablecompleted
NCT04517448
Quality of Life of Patients Over 75 Yars Undergoing Palliative ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06440174
Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)No drug interventionsNot AvailableNot Availablerecruiting
NCT04564482
PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT05804331
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03416244
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancertreatment2completed
NCT02489201
A Study of Donafenib Monotherapy in Advanced Oesophageal Cancertreatment1 / 2terminated
NCT04649372
EndoVE endosCopic Treatment for Oesophageal and Gastric canceRNo drug interventionstreatmentNot Availablecompleted
NCT03212469
A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancertreatment1 / 2active_not_recruiting
NCT03529669
Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal CancerNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT06046846
Prehabilitation Via a Mobile Application in Oesophago-gastric CancerNo drug interventionsotherNot Availablenot_yet_recruiting
NCT06031155
Swedish Esophageal and Cardia Cancer StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01361750
The Effects of Gastric Tube on the Quality of Life and Nutritional Status After Ivor-Lewis EsophagectomyNo drug interventionstreatmentNot Availableterminated
NCT05489250
The PLATON NetworkNo drug interventionsNot AvailableNot Availablerecruiting
NCT05600608
Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour LipidomeNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered MalignanciesNot AvailableNot Availableavailable
NCT04772989
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignanciestreatment1active_not_recruiting
NCT04871412
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage IIINo drug interventionstreatment3recruiting
NCT06605404
Pan-tumor MRD StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04999761
AB122 Platform Studytreatment1recruiting
NCT05177393
Treatment Outcomes of Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05383482
Afuresertib +Sintilimab+Chemotherapy in Patients with Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1treatment1 / 2active_not_recruiting
NCT05500508
Oral AMXT 1501 Dicaprate in Combination with IV DFMOtreatment1 / 2active_not_recruiting
NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT05706025
Study to Evaluate EnteroTracker® As a Sampling Method to Screen for Barrett's Esophagus/Esophageal CancerNo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT05953181
Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06008054
A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal TumorsNo drug interventionstreatment2recruiting
NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsNo drug interventionstreatment1recruiting
NCT06414902
18F-AraG PET/CT As a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal CancerNo drug interventionstreatment0recruiting
NCT06437288
Hematoporphyrin Photodynamic Therapy for Esophageal CancerNo drug interventionstreatment4not_yet_recruiting
NCT06445972
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)treatment1 / 2recruiting
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNo drug interventionstreatment1recruiting
NCT06469944
Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)treatment1 / 2recruiting
NCT06586242
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapytreatment2recruiting
NCT06587152
Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical SystemNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT03385343
Staging of Superficial EAC Using VLENo drug interventionsdiagnosticNot Availableterminated
NCT04654403
Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell CancertreatmentNot Availableunknown_status
NCT00474903
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagusprevention2completed
NCT03565003
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in Chinatreatment1 / 2unknown_status
NCT00003103
Chemotherapy in Treating Patients With Solid Tumorstreatment1 / 2completed
NCT01807390
Perspectives of Receiving Open Versus Minimally Invasive SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT02454790
Standard Follow-Up Program (SFP) for Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01704690
Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancertreatment2 / 3terminated
NCT06006390
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT01544790
Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic EsophagectomyNo drug interventionstreatment3completed
NCT00165464
Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancertreatment2completed
NCT05604664
Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic EsccNo drug interventionsNot AvailableNot Availablecompleted
NCT02424864
4D FDG PET in Esophageal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00003864
Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagustreatment2completed
NCT02497664
Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung CarcinomasNo drug interventionspreventionNot Availablecompleted
NCT04734821
Fluorescence Image Guided Foregut SurgeryNo drug interventionsotherNot Availablerecruiting
NCT00524121
Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancertreatment2completed
NCT04190121
Perioperative Nutritional Support in Esophageal Cancer PatientsNo drug interventionssupportive_careNot Availableunknown_status
NCT00003321
Quality-of-Life Assessment of Patients Who Have Cancer of the EsophagusNo drug interventionsNot AvailableNot Availablecompleted
NCT05431621
Establishment of Molecular Classification Models for Early Diagnosis of Digestive System CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT00502502
Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06037902
CPAP for Esophageal Cancer With RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT02689284
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancertreatment1 / 2completed
NCT03094884
Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancertreatment1recruiting
NCT00470184
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancertreatment2completed
NCT05480384
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junctiontreatment2recruiting
NCT05788484
A Study of CDX-585 in Patients With Advanced MalignanciesNo drug interventionstreatment1recruiting
NCT05450484
Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancerdiagnostic1recruiting
NCT00004879
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancertreatment1completed
NCT02326779
Low-dose Aspirin Therapy for Esophageal Cancertreatment3withdrawn
NCT01059643
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Necktreatment2completed
NCT01158287
Sorafenib. ICORG 06-41, V4treatment2completed
NCT04278287
Chemoradiotherapy in Unresectable Esophageal Cancertreatment1 / 2unknown_status
NCT01641887
Decision Aid for Gastroesophageal Reflux Disease ManagementNo drug interventionsNot AvailableNot Availableunknown_status
NCT00020787
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancertreatment3completed
NCT03139487
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolismtreatment2unknown_status
NCT04835987
Evaluation of the Autonomic Nervous System in Patients Undergoing Esophagectomy for CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00139633
Selective Dose Escalation for Esophageal Cancertreatment2unknown_status
NCT01333033
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapytreatment2completed
NCT00004233
S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomachtreatment2completed
NCT02534233
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal EpitheliumNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00072033
Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancertreatment2completed
NCT00394433
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancertreatment2completed
NCT00632333
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancertreatment1unknown_status
NCT03518554
A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumorstreatment1unknown_status
NCT00342654
Nutrition Intervention Trials in Linxian Follow-up StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01038154
Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancertreatment4unknown_status
NCT03757754
HPPH Photodynamic Therapy for Patients With Esophageal CancerNo drug interventionstreatment1unknown_status
NCT02545751
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancertreatment2unknown_status
NCT05056051
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's EsophagusNo drug interventionsdiagnosticNot Availablerecruiting
NCT02520453
Adjuvant Durvalumab for Esophageal Cancertreatment2unknown_status
NCT02448953
Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node InvolvementNo drug interventionstreatmentNot Availableunknown_status
NCT05591053
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in HumansNo drug interventionsdiagnosticNot Availablerecruiting
NCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacNo drug interventionstreatmentNot Availablerecruiting
NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignanciestreatment1completed
NCT04837677
A Study of PRT1419 in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00967577
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumorstreatment1completed
NCT05070247
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumorstreatment1 / 2recruiting
NCT00021047
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumortreatment1 / 2completed
NCT01444547
A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatintreatment2unknown_status
NCT05145647
To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT04074447
The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00008047
Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagustreatment1 / 2unknown_status
NCT00238147
Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancertreatment1completed
NCT00516347
Studying Genes for Barrett's Esophagus in Brothers and SistersNo drug interventionsNot AvailableNot Availableunknown_status
NCT06081647
The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy ProcedureNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT01175447
S-1 and Radiotherapy in Elderly Patients With Esophageal CancerNo drug interventionstreatment1completed
NCT00006245
Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxeltreatment2completed
NCT00732745
Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junctiontreatment1terminated
NCT00735345
Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinomatreatment2terminated
NCT02611245
NIR Fluorescence Imaging Technique in Thoracic Surgery With ICGtreatment1completed
NCT04390945
Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancertreatment2unknown_status
NCT01170845
Effect of Neutrophil Elastase Inhibitor on Lung Injury After EsophagectomyNo drug interventionstreatmentNot Availablecompleted
NCT01143545
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomastreatment1terminated
NCT05667298
Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal CancerNo drug interventionstreatment1recruiting
NCT03418298
Prehabilitation in Patients With Esophageal or Gastric CancersNo drug interventionstreatmentNot Availablecompleted
NCT01243398
Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After ChemotherapyNo drug interventionstreatment3completed
NCT01035398
Genetic and Environmental Risk Factors Related to Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03829098
TreatmENT of AnastomotiC Leakage After EsophagectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT00839605
Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedures and One-Lung VentilationNot AvailableNot Availablecompleted
NCT04581005
Prehabilitation in Esophageal Cancer CareNo drug interventionssupportive_careNot Availableunknown_status
NCT05342805
Comparison of Subtotal Stomach and Narrow Gastric Tube After EsophagectomyNo drug interventionstreatmentNot Availableunknown_status
NCT01958697
Age and Gender Corrected Body Mass IndexNo drug interventionsNot AvailableNot Availableunknown_status
NCT04843397
Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03818997
Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancertreatment2withdrawn
NCT06343597
Volume Outcome Relationships and EffectsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01191697
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancertreatment2active_not_recruiting
NCT00004897
Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancertreatment2terminated
NCT06451497
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid TumorsNo drug interventionsother1recruiting
NCT01341197
Fecal Screening Assay for Taiwanese PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT06381583
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal AdenocarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT04269083
A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric JunctionNo drug interventionstreatmentNot Availableunknown_status
NCT00002883
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagustreatment3completed
NCT05964361
First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer PatientsNo drug interventionstreatment1 / 2recruiting
NCT03144661
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other MalignanciesNo drug interventionstreatment1terminated
NCT01780961
Esophageal Cancer Tissue BankingNo drug interventionsNot AvailableNot Availablecompleted
NCT00165061
Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)No drug interventionstreatment3completed
NCT00445861
Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgerytreatment1 / 2completed
NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignanciestreatment1completed
NCT05412628
Investigating the Association Between Microbiota and Esophageal/Oropharyngeal CancerNo drug interventionsscreeningNot Availablerecruiting
NCT03314311
Rehabilitative Strategies Following Oesophageal CancerNo drug interventionstreatmentNot Availablecompleted
NCT04540211
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinomatreatment3active_not_recruiting
NCT04966611
Anlotinib for Esophageal Cancer (AFEC)Not AvailableNot Availableunknown_status
NCT00002711
Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagustreatment1completed
NCT00953511
Cologne Esophageal Response Prediction Study (CERP-Study)No drug interventionsdiagnosticNot Availablecompleted
NCT05978193
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell CarcinomaNo drug interventionstreatment2recruiting
NCT04986293
CPAP or BiPAP for Motion Mitigation During RadiotherapyNo drug interventionsotherNot Availablerecruiting
NCT04189393
Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT06453993
Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT04072393
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic CancersNo drug interventionssupportive_careNot Availableterminated
NCT02946671
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patientstreatment1completed
NCT03035071
Morbidity in Open Versus Minimally Invasive EsophagectomyNo drug interventionstreatmentNot Availablecompleted
NCT03908671
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00666978
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smokingtreatment4completed
NCT00891878
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junctiontreatment2completed
NCT06403878
Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancertreatment2recruiting
NCT01927978
Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05855278
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment2recruiting
NCT03676478
Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and SurvivalNo drug interventionstreatmentNot Availablerecruiting
NCT00650988
Cryotherapy for Barrett's Esophagus and Early Esophageal CancersNo drug interventionstreatment0completed
NCT04027088
Effect of Preoperative Immunonutrition in Upper Digestive TractNo drug interventionssupportive_careNot Availableunknown_status
NCT00281788
Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancertreatment1completed
NCT03535207
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00101907
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancertreatment1terminated
NCT00005607
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagustreatment2unknown_status
NCT00183807
A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancertreatment2terminated
NCT04846309
Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation TherapyNo drug interventionstreatment1recruiting
NCT02642809
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancerstreatment1completed
NCT04494009
Randomized Phase II Trial of a PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy(RHAPSODY)treatment2not_yet_recruiting
NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT02971956
Pembrolizumab in Refractory Advanced Esophageal Cancertreatment2completed
NCT00937456
Open Versus Laparoscopically-assisted Esophagectomy for CancerNo drug interventionstreatmentNot Availablecompleted
NCT03515356
Exercise to Reduce Chemotherapy-Induced Peripheral NeuropathyNo drug interventionssupportive_careNot Availablecompleted
NCT00014456
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT06181656
Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After ChemoradiationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04510285
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resectiontreatment2terminated
NCT01438385
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersNo drug interventionsNot AvailableNot Availableunknown_status
NCT06366685
Development and Initial Application of a Combined Exercise and Psychological Intervention Program for Patients After EsophagectomyNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT06027515
Esophageal Cancer Multimodal Prehabilitation StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT02209415
EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT03081715
PD-1 Knockout Engineered T Cells for Advanced Esophageal CancerNo drug interventionstreatmentNot Availablecompleted
NCT03415815
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT06275737
POP-UP: a Single-arm, Two-cohort Study: Trimodal Prehab for Upper GI and Pancreatic CancerNo drug interventionsotherNot Availablerecruiting
NCT02495337
Tissue Collection Protocol for Gastroesophageal CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003237
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomachtreatment2completed
NCT01034332
Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal CancerNo drug interventionstreatment2unknown_status
NCT05983432
Study to Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsNo drug interventionstreatment1recruiting
NCT00025532
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerNo drug interventionstreatment1withdrawn
NCT04359732
Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRINo drug interventionsdiagnosticNot Availablerecruiting
NCT01249352
A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancertreatment2 / 3completed
NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancertreatment1 / 2completed
NCT00093652
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancertreatment1 / 2terminated
NCT02810652
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical ResectionNo drug interventionssupportive_careNot Availablecompleted
NCT00344552
Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancertreatment2completed
NCT00154700
Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancertreatment2completed
NCT00525200
p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal CancerNot Available3completed
NCT03021200
Laser Fluorescence in Cancer Surgical TreatmentNo drug interventionstreatmentNot Availableunknown_status
NCT05494359
The Diagnostic Value of Nitrogen Element (N) in Esophagus CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06569459
Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancerprevention2recruiting
NCT04044859
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)No drug interventionstreatment1recruiting
NCT00040859
Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancertreatment2completed
NCT03174275
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinomatreatment2active_not_recruiting
NCT06558175
Reirradiation Dose Escalation in Thoracic CancersNo drug interventionstreatment1not_yet_recruiting
NCT04046575
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancertreatment1recruiting
NCT00561275
Safety Study of Multiple Peptide Vaccine to Esophageal CancerNo drug interventionstreatment1completed
NCT03985670
Teripalimab Plus Chemotherapy in Local Advanced Esophageal CancerNo drug interventionstreatment2unknown_status
NCT00938470
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junctiontreatment2completed
NCT04809870
Esophagectomy in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03731442
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patientstreatment3recruiting
NCT02547142
Early Integration of Palliative Care in Esophageal Cancer PatientsNo drug interventionssupportive_careNot Availableterminated
NCT00619242
The Effects of Sorafenib on Molecular Barrett's Esophagus CancertreatmentNot Availableterminated
NCT03671642
Perioperative Perfusion Measurement - a Feasibility and Usability StudyNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT02569242
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancertreatment3completed
NCT03234842
Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancertreatment2withdrawn
NCT04889742
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNo drug interventionstreatment2not_yet_recruiting
NCT03896399
Laparoscopic Ischemic Conditioning Prior to EsophagectomyNo drug interventionstreatmentNot Availableunknown_status
NCT01077999
Chemoradiation and Panitumumab for Esophageal Cancertreatment2completed
NCT00313599
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT00005599
Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancertreatment2completed
NCT00381706
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancertreatment2completed
NCT00002506
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancertreatment2completed
NCT04615806
The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in EsophagectomytreatmentNot Availableunknown_status
NCT01471249
Quality of Life and Dysphagia Following Palliative Stenting in Esophageal CancerNo drug interventionsNot AvailableNot Availableterminated
NCT01490749
Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancertreatment1completed
NCT00978549
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancertreatment3completed
NCT03413449
A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic SurgeryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05210049
Non-endoscopic Esophageal Sampling to Detect Barrett's Esophagus and Esophageal Cancer in VeteransNo drug interventionsscreeningNot Availablerecruiting
NCT03544736
Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)treatment1 / 2active_not_recruiting
NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT02633436
Research on the Role of SLC1A5 in the Development of Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00130936
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlatestreatment1 / 2terminated
NCT02838836
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT00903136
Tethered Capsule Endoscope in Screening Participants for Barrett EsophagusNo drug interventionsscreening1 / 2unknown_status
NCT00004236
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancertreatment2unknown_status
NCT05188313
TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancertreatment3recruiting
NCT02749513
Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patientsother0unknown_status
NCT02042313
Postoperative Pain Management After Minimally Invasive EsophagectomyNo drug interventionstreatment4unknown_status
NCT00659113
S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgerytreatment2unknown_status
NCT04609813
Esophageal cAncer Screening TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT03543813
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLNo drug interventionstreatment1 / 2completed
NCT01216813
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04152018
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.No drug interventionstreatment1active_not_recruiting
NCT06440018
INSPIRE: A Multi-Cancer Early Detection StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00003118
Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagustreatment3completed
NCT06012318
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00290719
Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgerytreatment1terminated
NCT04214119
EsophaCap for the Detection of Early Esophageal CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03474341
Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00477841
Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal CancerNo drug interventionstreatment2completed
NCT00971841
Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancertreatment2completed
NCT01808417
NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancerdiagnostic1completed
NCT02297217
Chemoradiotherapy for Advanced Esophageal Cancertreatment2recruiting
NCT01348217
Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagustreatment2 / 3completed
NCT00539617
Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgerytreatment2terminated
NCT02320734
Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomysupportive_care4completed
NCT02279134
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinomatreatment2 / 3active_not_recruiting
NCT03243734
trūFreeze® Palliative Esophageal CancerNo drug interventionssupportive_careNot Availablecompleted
NCT05369234
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitissupportive_care3recruiting
NCT00767234
Permission to Collect Blood Over Time for ResearchNo drug interventionsNot AvailableNot Availableterminated
NCT03462524
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary PhysiologyNo drug interventionsNot AvailableNot Availablecompleted
NCT00957424
Acceptability of Less Harmful Alternatives to CigarettesNot AvailableNot Availablecompleted
NCT06298916
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerNo drug interventionsdiagnostic1 / 2not_yet_recruiting
NCT05491616
Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Studytreatment2recruiting
NCT01043016
Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant TumorsNo drug interventionstreatment1unknown_status
NCT00209716
Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.treatment1 / 2completed
NCT06314516
Influence of Nutrition and Sarcopenia on Esophageal Cancer OutcomesNo drug interventionsNot AvailableNot Availablecompleted
NCT03570996
A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After EsophagectomyNo drug interventionstreatmentNot Availableterminated
NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNo drug interventionstreatment1 / 2completed
NCT04752358
ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2)No drug interventionstreatment2terminated
NCT05611658
Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CTNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05183958
A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancertreatment2not_yet_recruiting
NCT03410758
Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the OesophagusNo drug interventionsNot AvailableNot Availablecompleted
NCT03161535
Effectiveness of a Rehabilitation Program in Improving Quality of Life in Patients With Esophageal CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00019435
LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT00319735
Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction CarcinomasNo drug interventionstreatment2completed
NCT04066335
Study to Evaluate the Safety of Nanoxel M Inj.No drug interventionsNot AvailableNot Availableunknown_status
NCT05812235
Bone Microstructure by Using HR-pQCT After EsophagectomyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02644863
Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancertreatment2unknown_status
NCT02157363
POsitioning for Esophageal Cancer ResectionNo drug interventionstreatmentNot Availableterminated
NCT02574663
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumorstreatment1completed
NCT00012363
S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagustreatment2completed
NCT02358863
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and StomachtreatmentNot Availableterminated
NCT00524186
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancertreatment1terminated
NCT06558786
Registry for Esophageal and Gastroesophageal Junction CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01661686
Fully Covered or Partially Covered Stents in Malignant Esophageal StricturesNo drug interventionstreatmentNot Availablecompleted
NCT02735239
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancertreatment1 / 2completed
NCT04217239
A Comparison Between Ivor-Lewis and McKeown Minimally Invasive EsophagectomyNo drug interventionstreatmentNot Availablerecruiting
NCT02970539
Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancerstreatment1unknown_status
NCT02379039
Multimodal Monitoring of Radiotherapy Response in Squamous Cell CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00022139
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junctiontreatment2completed
NCT01107639
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgerytreatment3completed
NCT04425122
The Microbiome of Oesophageal Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04280822
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal CarcinomaNo drug interventionstreatment3recruiting
NCT05787522
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at RiskNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003125
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumorstreatment2completed
NCT00019825
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleuratreatment1completed
NCT02609425
Intrathoracic Esophagogastric Anastomosis After Robot Assisted Minimally Invasive Esophagectomy Using STRATAFIXNo drug interventionsNot AvailableNot Availablecompleted
NCT00425425
Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancertreatment1 / 2unknown_status
NCT06168825
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive InterventionNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05405530
Nasal Mask Kit in Gastrointestinal EndoscopyNo drug interventionspreventionNot Availableunknown_status
NCT05539430
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaNo drug interventionstreatment1recruiting
NCT01930630
ESI With EUS to Differentiate T3 and T4 ESCCNo drug interventionsdiagnostic1unknown_status
NCT00681330
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal CancerNo drug interventionstreatment1 / 2completed
NCT01998230
Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal CancerNo drug interventionstreatment3completed
NCT05082948
Migration Rates of Sutured vs Non-sutured Esophageal Stent PlacementNo drug interventionstreatmentNot Availablecompleted
NCT02662348
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive Systemtreatment1unknown_status
NCT00003748
Irinotecan in Treating Patients With Esophageal or Stomach Cancertreatment2completed
NCT01293448
Evaluation of Balloon-based Cryoablation of Human Esophageal EpitheliumNo drug interventionstreatmentNot Availablecompleted
NCT00987857
Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett EsophagusNo drug interventionsscreeningNot Availableunknown_status
NCT00033657
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancertreatment2completed
NCT03292757
FLOTOR Pilot Studyother1 / 2completed
NCT05543057
Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision RadiotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00701857
Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancertreatment1completed
NCT03734926
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid TumorsNo drug interventionstreatment1unknown_status
NCT00899626
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCtreatment1 / 2recruiting
NCT03529266
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage for Esophageal or Junctional Carcinoma.treatment2completed
NCT01824966
Signet Ring Cell Carcinoma in Esophageal AdenocarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT04460066
A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.treatment1 / 2unknown_status
NCT06335966
BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an EndoscopyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02639065
A Study of Durvalumab (MEDI4736) in Esophageal Cancertreatment2completed
NCT03671265
Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCCtreatmentNot Availableunknown_status
NCT04014465
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03428074
A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01054274
a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation StentNo drug interventionstreatment3unknown_status
NCT01738620
Quality of Life After Esophagectomy for Cancer - Step 1No drug interventionstreatmentNot Availableterminated
NCT00911820
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancertreatment2completed
NCT03286920
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumorstreatment1active_not_recruiting
NCT04248582
Cryotherapy for Locally Advanced Esophageal CancerNo drug interventionstreatment1active_not_recruiting
NCT02607982
CCRT for Esophageal Cancer.treatment2completed
NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumorstreatment1terminated
NCT00865982
Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancertreatment2unknown_status
NCT00357682
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasiaprevention3unknown_status
NCT05187182
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancertreatment1recruiting
NCT00623831
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenNo drug interventionstreatment1completed
NCT06219031
A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00002631
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagustreatment3completed
NCT00291473
Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancerstreatment1completed
NCT03835273
Oesophagectomy and Chest Wall and Respiratory FunctionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04938973
NIF-Guided RAMIE Using ICG Versus OTE Feasibility RCTNo drug interventionstreatmentNot Availablerecruiting
NCT00004127
Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomachtreatment2completed
NCT00924027
A Study of Patients Receiving High-Dose Rate BrachytherapyNo drug interventionstreatment2active_not_recruiting
NCT01447927
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagusprevention2completed
NCT03283527
Organoid Based Response Prediction in Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00727376
Evaluation of Polyflex Stenting in Esophageal Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00003076
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagusprevention2completed
NCT00655876
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancertreatment3completed
NCT00005876
Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgerytreatment2unknown_status
NCT03377660
Resection of the Esophagus and Subsequent Weight LossNo drug interventionsNot AvailableNot Availableterminated
NCT00654160
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancertreatment1completed
NCT04162860
Preemptive Endoluminal Negative Pressure in Minimally Invasive Transthoracic EsophagectomyNo drug interventionspreventionNot Availableunknown_status
NCT00448760
Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgerytreatment2completed
NCT05245760
ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancertreatment2withdrawn
NCT06339060
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).No drug interventionstreatment3recruiting
NCT01640860
Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06469060
Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric JunctionNo drug interventionstreatment2not_yet_recruiting
NCT01401894
Perception Prognosis, Goals of Treatment, and CommunicationNo drug interventionsNot AvailableNot Availablecompleted
NCT06165094
Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients With Thoracic Esophageal Squamous Cell Carcinoma: An Observational StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02960594
hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapseprevention1completed
NCT00900094
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00861094
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancertreatment2 / 3completed
NCT05480891
Transnasal Esophagoscopy (TNE) Esophageal Cancer ScreeningNo drug interventionsNot AvailableNot Availablerecruiting
NCT01254591
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT00335491
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT04694391
Genomic Study of Relapse Esophageal Cancer After RadiotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05276791
EMR Versus ESD for Barrett's NeoplasiaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00041262
Combination Chemotherapy in Treating Patients With Esophageal Cancertreatment3unknown_status
NCT03937362
Pre-Surgery If Needed for Oesophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00030862
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagustreatment2completed
NCT00766480
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagustreatmentNot Availableunknown_status
NCT00009880
Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomachtreatment2completed
NCT01627080
Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and RadiationNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06346080
Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice ExperimentNo drug interventionsotherNot Availablerecruiting
NCT04652180
Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy .No drug interventionstreatmentNot Availablerecruiting
NCT00531180
4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic MalignanciesNo drug interventionsdiagnostic2completed
NCT00051480
Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal CancerNo drug interventionstreatment2completed
NCT03211780
Use of Intra-Operative Shear Wave Ultrasound Vibrometry for Characterization of Esophageal Malignant TumorsNo drug interventionsdevice_feasibilityNot Availableterminated
NCT02812680
The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal AdenocarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT05542680
Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02372929
Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02138929
LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinomatreatment1completed
NCT03099629
Efficacy of Inspiratory Muscle Training on Respiratory Performance in Patients With Esophageal Cancer Receiving Combined Modality TherapyNo drug interventionspreventionNot Availablecompleted
NCT01034189
Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancertreatment2unknown_status
NCT00836992
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00003192
Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagustreatment2completed
NCT00601692
Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancertreatment1completed
NCT05086692
A Beta-only IL-2 ImmunoTherapY Studytreatment1 / 2recruiting
NCT00985192
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancertreatment2completed
NCT04656392
Early Detection of Barrett's Esophagus in Participants With Reflux Symptoms in Primary CareNo drug interventionsdiagnosticNot Availablecompleted
NCT00963092
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00911092
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal CancerNot Available4completed
NCT02465892
Pillars4Life TrialNo drug interventionssupportive_careNot Availablecompleted
NCT00753844
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal CancerNo drug interventionstreatment1completed
NCT04958044
Endoscopic Assisted Calcium Electroporation in Esophageal Cancersupportive_care1completed
NCT06419244
Myosteatosis in Oeso-gastric Cancer: Clinical ImpactsNo drug interventionsbasic_scienceNot Availablerecruiting
NCT01038544
Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05830240
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck CancerNo drug interventionstreatment0recruiting
NCT00588640
Study of D-Methadone in Patients With Chronic Paintreatment1 / 2completed
NCT04616040
A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal CancerNot AvailableNot Availablenot_yet_recruiting
NCT04464967
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancerstreatment1 / 2withdrawn
NCT04520867
STRENGTH ExpansionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03840967
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinomatreatment2terminated
NCT05191667
AN0025 and Chemoradiotherapy Combination in Esophageal Cancertreatment1suspended
NCT04566367
Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck CancerNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT05817201
Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategytreatment2 / 3recruiting
NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancertreatment1 / 2active_not_recruiting
NCT05471401
GI Organ Tracking Via Balloon ApplicatorsNo drug interventionsdevice_feasibilityNot Availablewithdrawn
NCT02689401
MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancerdiagnostic1withdrawn
NCT04688801
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03991104
SOX-based CRT for Esophageal Cancer.treatment1 / 2withdrawn
NCT02347904
Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancertreatment1completed
NCT00154804
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancertreatment2completed
NCT05318404
Conventional Oral Intake vs Delayed Oral Intake With Jejunostomy Feeding After Esophagectomy (JNS Study)No drug interventionstreatmentNot Availablecompleted
NCT03662204
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT02491372
A Pilot Study of the Effectiveness of Acceptance and Commitment Therapy With a Post-Upper GI Cancer PopulationNo drug interventionstreatmentNot Availablewithdrawn
NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasistreatment1terminated
NCT03120572
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02850172
Effects of a "Walk, Eat, & Breathe" Nursing Intervention For Patients With Esophageal CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT01962272
The Effect of Nutritional Counseling for Cancer PatientsNo drug interventionssupportive_care4completed
NCT00754468
Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.No drug interventionstreatment4completed
NCT00060268
Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal TumorsNo drug interventionstreatment1 / 2completed
NCT00628368
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT01522768
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancertreatment2completed
NCT04673968
Prehabilitation on Fitness, Surgical Outcomes and Mitochondria Functionality in Patients With Esophageal CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT04269369
Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patientstreatment4unknown_status
NCT05894369
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04426669
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineeringtreatment1 / 2recruiting
NCT02427269
University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer BiorepositoryNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00686569
Mediastinal Microdialysis in Patients With Oesophageal or Cardia Cancer Treated by ResectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00012246
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tracttreatment2terminated
NCT05314946
Nutritional Support During Induction Therapy for Esophageal CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT01386346
Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancertreatment1completed
NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversNo drug interventionssupportive_care3completed
NCT02274012
Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatmenttreatment2withdrawn
NCT04251312
Minimizing Pathologic Aspiration in Patients Undergoing Esophageal and Lung Resections for CancerNo drug interventionspreventionNot Availablecompleted
NCT02133612
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinomatreatment2completed
NCT04383210
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumorstreatment2active_not_recruiting
NCT06424210
The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1)No drug interventionsNot AvailableNot Availablecompleted
NCT05967910
The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study)No drug interventionsNot AvailableNot Availablerecruiting
NCT05866510
Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancertreatment2recruiting
NCT00052910
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancertreatment3completed
NCT04219410
Assessment of a Modified Minimally Invasive EsophagectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT01952210
Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer PatientNo drug interventionspreventionNot Availablecompleted
NCT04161781
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00217581
Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancertreatment2completed
NCT00003381
Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]No drug interventionsNot AvailableNot Availableterminated
NCT01048281
Clinical & Pathological Studies of Upper Gastrointestinal CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00113581
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancertreatment1completed
NCT00215995
Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomastreatment2completed
NCT04192695
Esophageal Squamous Cell Cancer Surveillance With CytospongeNo drug interventionsdiagnosticNot Availablecompleted
NCT04996095
The Registry Study of Genetic Alterations of Esophageal Cancer in TaiwanNo drug interventionsNot AvailableNot Availablerecruiting
NCT01301495
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the EsophagusNo drug interventionstreatment2withdrawn
NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplificationstreatment1recruiting
NCT03113214
PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal CancerNo drug interventionstreatmentNot Availablecompleted
NCT00400114
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancertreatment2completed
NCT00686114
Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancertreatment3unknown_status
NCT06306755
Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric CancerNo drug interventionsscreeningNot Availablerecruiting
NCT06019455
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.No drug interventionsNot AvailableNot Availablerecruiting
NCT00003055
Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancertreatment2completed
NCT04426955
Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancertreatment3unknown_status
NCT06304350
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinomatreatment2recruiting
NCT00109850
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancertreatment2terminated
NCT05831150
Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical ResearchNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05708950
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)treatment1 / 2recruiting
NCT00032123
Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancertreatment2completed
NCT00453323
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancertreatment2unknown_status
NCT01291823
Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancertreatment2unknown_status
NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer DiagnosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01003808
Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancertreatment1completed
NCT00365508
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smokingtreatment4completed
NCT02146508
Endoscopic Prevention of Esophageal Cancer at Tenwek HospitalNo drug interventionstreatmentNot Availablesuspended
NCT00815308
Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinomatreatment2completed
NCT00439608
Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancertreatment2completed
NCT00021138
Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop SmokingpreventionNot Availablecompleted
NCT00075738
Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancertreatment2unknown_status
NCT06123338
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancertreatment2recruiting
NCT04821843
Neoadjuvant Treatment Modalities in Esophageal Cancertreatment3recruiting
NCT02461043
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinomatreatment3unknown_status
NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesNo drug interventionstreatment1completed
NCT03917043
APG-2449 in Patients With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT00017043
BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapytreatment2completed
NCT05865743
Perioperative SDD to Prevent Infectious Complications After EsophagectomyNo drug interventionsprevention3not_yet_recruiting
NCT05615103
The PET-CT Predicting Response to Immunochemotherapy in Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03804203
Short Course Radiation Therapy in Palliative Treatment of Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT06010303
A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinomatreatment2active_not_recruiting
NCT05460403
Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 ResectionNo drug interventionsNot AvailableNot Availableunknown_status
NCT04822103
A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01256203
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible LightNo drug interventionsprevention2withdrawn
NCT01624090
Mithramycin for Lung, Esophagus, and Other Chest Cancerstreatment2terminated
NCT00209690
Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.treatment1 / 2completed
NCT04135664
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell CarcinomaNo drug interventionstreatment3recruiting
NCT04354064
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01691664
Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT06501664
Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCCtreatment3not_yet_recruiting
NCT00511264
Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal TractNo drug interventionsNot AvailableNot Availablecompleted
NCT00537121
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancertreatment1completed
NCT02653521
The Clinical Physics Research of Image Guided Adaptive Radiation Therapy for Esophagus CancerNo drug interventionstreatmentNot Availableunknown_status
NCT02452021
Pencil Beam Scanning Proton Radiotherapy for Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00681421
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal CancerNo drug interventionstreatment1 / 2completed
NCT01372202
CHFR Methylation Status Esophageal Cancer Studytreatment2terminated
NCT06452602
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.treatment2not_yet_recruiting
NCT00002984
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagustreatment1 / 2completed
NCT05718284
High Flow Nasal Cannula After EsophagectomyNo drug interventionstreatmentNot Availablerecruiting
NCT01995084
In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT00002884
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagustreatment3unknown_status
NCT05572684
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumorstreatment1 / 2recruiting
NCT00702884
Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancertreatment2completed
NCT00533884
Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer ClinicNo drug interventionsNot AvailableNot Availablecompleted
NCT00354679
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancertreatment2completed
NCT02448979
Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic ApproachNo drug interventionstreatment3unknown_status
NCT03936179
High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasistreatment1 / 2recruiting
NCT04028479
The Registry of Oncology Outcomes Associated With Testing and TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT03962179
Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)No drug interventionstreatmentNot Availableunknown_status
NCT01051479
A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancerdiagnostic1completed
NCT06129487
Evaluations of Alcohol Warning LabelsNo drug interventionspreventionNot Availablecompleted
NCT00003087
Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagustreatment2completed
NCT00376987
Zinc Supplements in Lowering Cadmium Levels in SmokersNo drug interventionsprevention2completed
NCT02598687
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.treatment1withdrawn
NCT01738633
Quality of Life After Esophagectomy for Cancer - Step 2No drug interventionstreatmentNot Availableterminated
NCT02129933
VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesionsdiagnostic1completed
NCT01551433
Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis EsophagectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT01366833
Optimal Management of Malignant DysphagiaNo drug interventionssupportive_careNot Availableterminated
NCT06346054
Molecular Assessment for Gastro-Esophageal CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT03213054
A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancertreatment1unknown_status
NCT03551951
Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowNo drug interventionsNot AvailableNot Availablerecruiting
NCT00002951
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancertreatment2completed
NCT06410651
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinomatreatment2recruiting
NCT01747551
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancertreatment2completed
NCT03094351
Robot-assisted Esophagectomy Versus Conventional Thoracoscopic EsophagectomyNo drug interventionstreatment3recruiting
NCT00230451
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinomatreatment2completed
NCT00730353
Sutent + Taxol for Advanced Esophageal Cancertreatment2completed
NCT02729753
Clinical Study to Evaluate CryoBalloon™ Full and Swipe Ablation Systems for Ablation of Human Esophageal EpitheliumNo drug interventionsbasic_scienceNot Availablecompleted
NCT04415853
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancertreatment3unknown_status
NCT03764553
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancertreatment2recruiting
NCT00670553
A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancertreatment1completed
NCT01525953
Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT00069953
Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junctiontreatment2completed
NCT00836277
Phase II Study of Irinotecan and Panitumumabtreatment2completed
NCT01416077
Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal ResectionNo drug interventionstreatment4completed
NCT00867477
PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric OxideNo drug interventionsscreening2completed
NCT05937477
Developing Artificial Intelligence-based Algorism to Predict Side Effects and Symptoms From ChemotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06101277
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)No drug interventionstreatmentNot Availablerecruiting
NCT00201747
Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancertreatment2completed
NCT00582647
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04695847
M1231 in Participants With Solid TumorsNo drug interventionstreatment1completed
NCT01998347
Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancertreatment3withdrawn
NCT03397745
Bispectral Index Throughout Esophageal Cancer OperationNo drug interventionsotherNot Availablecompleted
NCT05105945
Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical EsophagectomyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02221245
Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT00100945
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancertreatment2completed
NCT02634645
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)No drug interventionsNot AvailableNot Availablerecruiting
NCT03649945
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancertreatment2unknown_status
NCT05789498
Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05697198
PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineNo drug interventionsNot AvailableNot Availablerecruiting
NCT05303298
Evaluating Acid Reflux After Oesophageal Stenting Using Anti-reflux StentsNo drug interventionspreventionNot Availablerecruiting
NCT00183898
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancertreatment2unknown_status
NCT06293898
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumorstreatment1recruiting
NCT06499298
Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction CancerNot AvailableNot Availablenot_yet_recruiting
NCT00601705
Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomachtreatment2completed
NCT01463605
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trialtreatment2completed
NCT00722605
Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic CancerNo drug interventionsdiagnostic1 / 2completed
NCT06398405
A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous CancerNo drug interventionstreatment2recruiting
NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00665197
Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer DysphagiaNo drug interventionstreatment3completed
NCT03756597
PAN-study: Pan-Cancer Early Detection Study (PAN)No drug interventionsNot AvailableNot Availablecompleted
NCT00002897
Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagustreatment3completed
NCT02213497
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancerdiagnostic1active_not_recruiting
NCT00258297
Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgerytreatment2terminated
NCT01393483
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00848783
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancerstreatment2terminated
NCT00020761
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomachtreatment2completed
NCT00509561
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancertreatment2 / 3unknown_status
NCT02745561
Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.treatment2unknown_status
NCT02239328
A Study of Patient-reported Outcomes in Patients With Lung or Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03556228
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphomatreatment1recruiting
NCT01172028
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT01851928
Validation of a Nutrition Screening ToolNo drug interventionsNot AvailableNot Availablecompleted
NCT01927328
Iron Replacement in Oesophagogastric Neoplasiatreatment4unknown_status
NCT01044511
Quality of Life With Esophageal Stent TrialNo drug interventionssupportive_careNot Availableunknown_status
NCT03384511
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.treatment4completed
NCT05517811
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05432193
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)treatment1active_not_recruiting
NCT03642093
HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo SurgeryNo drug interventionstreatment4unknown_status
NCT02570893
A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinomatreatment3unknown_status
NCT03029793
Biomarkers and Functional Imaging in Predicting Response of Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00831571
Prospective Analysis of Hypersensitivity Reactions to OxaliplatinNo drug interventionsNot AvailableNot Availablecompleted
NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancerstreatment1recruiting
NCT05846971
Clinical Utility of Methylation-based Prognostic Assay for Barrett's EsophagusNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT06392971
Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitisprevention2recruiting
NCT01267578
Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)No drug interventionstreatment2unknown_status
NCT00005878
Celecoxib to Prevent Cancer in Patients With Barrett's Esophagusprevention2completed
NCT04316078
A Novel Patient Engagement Platform Among Patients With Gastrointestinal MalignanciesNo drug interventionshealth_services_researchNot Availablecompleted
NCT06097078
Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06022978
Submucosal Saline Injection Followed by Endoscopic UltrasoundNo drug interventionsdiagnosticNot Availablerecruiting
NCT03081988
Prediction Model of Response for CCRT in Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02716688
S-1 and Radiotherapy for Elderly Esophageal Cancer PatientsNo drug interventionstreatment2withdrawn
NCT01102088
Simultaneous Integrated Boost (SIB) in Esophageal CancerNo drug interventionstreatment1completed
NCT02139488
Organ Motion and Early Tumor Response MeasurementNo drug interventionsNot AvailableNot Availablecompleted
NCT06263088
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.No drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00450788
Esophageal Cancer in Northeastern IranNo drug interventionsNot AvailableNot Availablecompleted
NCT00238407
Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgerytreatment2completed
NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal MalignanciesNo drug interventionssupportive_careNot Availablecompleted
NCT02297607
Routine Post-Operative Supplemental NutritionNo drug interventionssupportive_careNot Availableterminated
NCT05944809
The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patientsprevention2recruiting
NCT03095209
Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by SurgeryNot AvailableNot Availablecompleted
NCT02924909
Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancertreatment2unknown_status
NCT00017056
BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapytreatment2completed
NCT01404156
Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinomatreatment2 / 3completed
NCT03740256
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsNo drug interventionstreatment1recruiting
NCT05899985
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical InvestigationNo drug interventionstreatmentNot Availablerecruiting
NCT00260585
Esophageal Cancer Risk RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00525915
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinomatreatment2completed
NCT00310115
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyNo drug interventionsNot AvailableNot Availablecompleted
NCT04776837
Predicting Disease Progression and/or Recurrence in CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00268437
Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgerytreatment2terminated
NCT02544737
Apatinib for Metastatic Esophageal Cancer.treatment2unknown_status
NCT00003137
Irinotecan in Treating Patients With Advanced Cancer of the Stomachtreatment2completed
NCT03787537
Nutritional Status and Nutrient Supply in Hospitalised Surgical PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05169437
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumorstreatment2active_not_recruiting
NCT04913337
Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignanciestreatment1 / 2active_not_recruiting
NCT03990532
Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00072332
Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumorstreatment1completed
NCT03587532
Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer SurgeryNo drug interventionsdiagnosticNot Availablerecruiting
NCT04545632
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating FactorNo drug interventionsNot AvailableNot Availablecompleted
NCT05617352
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT06498752
MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal CancerNo drug interventionstreatment2recruiting
NCT00137852
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancertreatment2completed
NCT06500052
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsNo drug interventionstreatment1recruiting
NCT00566800
Erlotinib in Treating Patients With Barrett Esophagustreatment1unknown_status
NCT05396300
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT00016900
PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagustreatment2completed
NCT06431100
a Single-arm, Single-center, Open Clinical StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00260559
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of LifeNo drug interventionsNot AvailableNot Availablerecruiting
NCT02283359
Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagustreatment1terminated
NCT00551759
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancertreatment2terminated
NCT00160875
Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancertreatment2 / 3completed
NCT05415475
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT01770275
UICC Classification of Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03061370
Sarcopenia and Visceral Obesity in Esophageal and Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01760070
Comparison of O-type Hybrid Knife and IT Knife in ESDNo drug interventionstreatmentNot Availablecompleted
NCT00010270
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerNo drug interventionstreatment1unknown_status
NCT05030870
Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly PatientsNo drug interventionspreventionNot Availablecompleted
NCT01950442
Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05633342
Project CADENCE (CAncer Detected Early caN be CurEd)No drug interventionsNot AvailableNot Availablerecruiting
NCT03151642
A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATIONNo drug interventionsNot AvailableNot Availablecompleted
NCT00339742
Stomach and Esophageal Cancers in Northern IranNo drug interventionsNot AvailableNot Availablecompleted
NCT04896242
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06413342
Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinomatreatment2recruiting
NCT06484842
Evaluation of the Effectiveness of the Combined Psychological Resilience and Self-efficacy Intervention for Improving Resilience and Self-efficacy and Reducing Anxiety and Depression of Oesophageal Cancer Surgery PatientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT02457299
Esophagectomy With or Without Prior Ischemic Gastric PreconditioningNo drug interventionstreatmentNot Availableterminated
NCT02012699
Integrated Cancer Repository for Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT00333099
INEC Study: Immuno-modulating Enteral Nutrition in CancerNo drug interventionsNot Available4completed
NCT06532799
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancertreatment1 / 2not_yet_recruiting
NCT01787006
Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancertreatment2completed
NCT01959906
Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer.No drug interventionsNot AvailableNot Availableunknown_status
NCT03457506
Intra-individual Comparison of Conventional and Digital PET/CT ScannersNo drug interventionsdiagnosticNot Availablecompleted
NCT01582906
A Survivorship Care Plan for Gynaecological Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06060106
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT00199849
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccinetreatment1completed
NCT04892849
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and RadiotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01806649
BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapytreatment2terminated
NCT01766349
Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04894149
Prehabilitation and Rehabilitation for Patients With Oesophageal CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT01135849
B-Receptor Signaling in CardiomyopathyNo drug interventionsNot AvailableNot Availablecompleted
NCT01843049
Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal CancerNo drug interventionstreatment1 / 2unknown_status
NCT00497549
Trial Comparing Side-to-Side Stapled and Hand-sewn Esophagogastric Anastomosis in NeckNo drug interventionstreatmentNot Availablecompleted
NCT02954536
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancertreatment2completed
NCT03413436
Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinomatreatment4completed
NCT00281736
Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal CancerNo drug interventionstreatment2completed
NCT00137813
Avastin and Taxotere for Esophagogastric Cancertreatment2completed
NCT03335813
Endoesophageal Brachytherapy for Patients With Esophageal CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01836913
Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05007613
Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinomatreatment2unknown_status
NCT00826813
Trial Using 125I Embedded Stent in Patients With Advanced Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT03044613
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancertreatment1active_not_recruiting
NCT00019513
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomastreatment1completed
NCT02273713
The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)treatment1 / 2completed
NCT02055313
Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual SurvivalNo drug interventionsNot AvailableNot Availablecompleted
NCT01065818
Early Prediction of Pathology Response of Chemoradiotherapy With FLT PETdiagnosticNot Availableterminated
NCT04207918
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancertreatment2completed
NCT03668418
Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosNot AvailableNot Availableunknown_status
NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumorstreatment1active_not_recruiting
NCT06161818
Total Neoadjuvant Therapy for Adenocarcinoma of the OESophagus and Oesophagogastric Junction: TNT-OES-2 TrialNo drug interventionstreatment2not_yet_recruiting
NCT06116019
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)No drug interventionsNot AvailableNot Availablerecruiting
NCT01368419
Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patientstreatment2unknown_status
NCT01243619
FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00900419
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersNo drug interventionsNot AvailableNot Availablerecruiting
NCT05443841
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)No drug interventionsNot AvailableNot Availablerecruiting
NCT00585741
Pilot Study of 18F-FLT PETNo drug interventionstreatmentNot Availableterminated
NCT01957241
PLA for HCC and Esophageal ca SerumNo drug interventionsNot AvailableNot Availableunknown_status
NCT01551641
Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancertreatment2unknown_status
NCT03115541
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal ResectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00107341
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junctiontreatment2completed
NCT03461341
European iNvestigation of SUrveillance After Resection for Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04424641
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsNo drug interventionstreatment1 / 2terminated
NCT02869217
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumorstreatment1active_not_recruiting
NCT00585117
Pilot Study of (61)CuATSM-PET Imaging in Cancer PatientsNo drug interventionsdiagnosticNot Availableterminated
NCT01077817
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)Not AvailableNot Availablecompleted
NCT04512417
A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancertreatment2unknown_status
NCT00598117
Quality Of Life Outcomes Following Treatment for Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01349517
Health-related Quality of Life of Patients With Esophageal Cancer After SurgeryNo drug interventionstreatment2unknown_status
NCT05565417
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomastreatment1 / 2recruiting
NCT04825834
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)No drug interventionsNot AvailableNot Availablerecruiting
NCT03468634
Raman Probe for In-vivo Diagnostics (During Oesophageal) EndoscopyNo drug interventionsdiagnosticNot Availablecompleted
NCT03910634
IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patientstreatment2unknown_status
NCT00583934
Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?No drug interventionsNot AvailableNot Availablecompleted
NCT01010334
Comparison of Standard of Care or Treatment on ProtocolNo drug interventionsNot AvailableNot Availableterminated
NCT01242124
Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis OesophagectomyNo drug interventionstreatment2 / 3unknown_status
NCT00505024
Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic SurgeryNo drug interventionssupportive_careNot Availablecompleted
NCT03558724
Fluorescence Endoscopy of Esophageal Carcinomadiagnostic1terminated
NCT02074124
CT Perfusion Changes in GI Cancer During Adenosine Vasodilation TestNo drug interventionsNot AvailableNot Availablecompleted
NCT00066716
Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagustreatment2completed
NCT06418516
Early Detection of Esophageal Squamous Cancer With the Capsule Sponge DeviceNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04984096
Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00086996
S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junctiontreatment2completed
NCT05706558
Retrospective Review of Esophageal Cancer at MSKCCNo drug interventionsNot AvailableNot Availablerecruiting
NCT00995358
A Study With Peptide Vaccination in Treating Patients With Esophageal CancerNo drug interventionstreatment2unknown_status
NCT04576858
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04286958
A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCCtreatment2unknown_status
NCT00416858
Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgerytreatment3completed
NCT02375958
PCA062 in pCAD-positive Tumors.No drug interventionstreatment1completed
NCT01666158
Prehabilitation for Esophageal Resection SurgeryNo drug interventionshealth_services_researchNot Availablecompleted
NCT04188535
Serial MRI Scans During Radiation TherapyNo drug interventionsotherNot Availablerecruiting
NCT03216135
Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal AdenocarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00004235
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomachtreatment2completed
NCT00002935
Photodynamic Therapy in Treating Patients With Early Esophageal Cancertreatment2completed
NCT03285035
Quality of Life Assessment of Cryotherapy in Esophageal or Gastroesophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02205463
KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancertreatment1withdrawn
NCT01894763
Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant DysphagiaNo drug interventionstreatment1completed
NCT06061263
Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant ChemoradiotherapyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03736863
Study of Anti-PD-1/PD-L1 Antibody Plus Apatinib as Second-Line Treatment of Advanced Esophageal Squamous Celltreatment2recruiting
NCT00629863
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal CancerdiagnosticNot Availablecompleted
NCT01203163
Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety OutcomesNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03082586
Radiation Dose Escalation in Esophageal CancerNo drug interventionstreatmentNot Availablecompleted
NCT00063986
Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal CancerNo drug interventionstreatment2completed
NCT04526886
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX ChemotherapyNo drug interventionstreatmentNot Availablecompleted
NCT03273686
Efficacy of Nasogastric Tube Application in Postoperative Care of EsophagectomyNo drug interventionstreatment3unknown_status
NCT01913639
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancertreatment2completed
NCT03110939
Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT06429839
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patientstreatment2recruiting
NCT06312839
Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric ConditioningNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01868139
Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)No drug interventionstreatmentNot Availableterminated
NCT02489422
Programs To Support You During ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT03132922
MAGE-A4ᶜ¹º³²T for Multi-TumorNo drug interventionstreatment1active_not_recruiting
NCT00493025
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgerytreatment2terminated
NCT00002625
Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphomatreatment1completed
NCT01144325
Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus PositionNo drug interventionstreatment2unknown_status
NCT00642525
Detection of Anastomotic Leakage After Esophageal SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT00833625
FDG-PET-CT and Biomarkers in Esophageal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05704530
Liquid Biopsies in Esophageal CancerNo drug interventionsbasic_scienceNot Availablerecruiting
NCT00002930
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by SurgeryNo drug interventionsdiagnostic2 / 3completed
NCT06385730
Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)No drug interventionstreatment2recruiting
NCT00747448
CryoSpray Ablation (TM) GI Patient RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT01558648
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00387348
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancersupportive_care3terminated
NCT02125448
PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05055648
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyNo drug interventionstreatmentNot Availablerecruiting
NCT03409848
Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinomatreatment2completed
NCT03816748
The Efficacy of Postoperative Application of HFNC at Acute Phase for Minimally Invasive Esophagectomy Surgery PatientsNo drug interventionstreatmentNot Availablecompleted
NCT00004257
Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancertreatment1completed
NCT00054457
Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junctiontreatment2completed
NCT00759226
Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancertreatment2completed
NCT03727126
Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00735826
A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancerbasic_scienceNot Availablecompleted
NCT00003326
Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagustreatment2unknown_status
NCT02017366
Design of the EFECTS TrialNo drug interventionsbasic_scienceNot Availablewithdrawn
NCT03244566
PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)No drug interventionsNot AvailableNot Availablecompleted
NCT02448966
Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic EsophagectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06198465
Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinomatreatment2not_yet_recruiting
NCT05504265
Perioperative Analgesia Modes in Minimally Invasive Esophagectomytreatment2 / 3unknown_status
NCT03403465
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal CancersNo drug interventionsother2recruiting
NCT04504565
99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal CarcinomaNo drug interventionsdiagnosticNot Availableunknown_status
NCT06275165
The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT00686465
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility StudyNo drug interventionstreatmentNot Availablecompleted
NCT01446874
Prevention of Post-operative Pneumonia (POPP)prevention2 / 3terminated
NCT03712774
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02762474
Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancertreatment1 / 2unknown_status
NCT01630174
IMRT/Pemetrexed/Cisplatin in Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02853474
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line ChemotherapyNo drug interventionssupportive_care3completed
NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT04958720
Spanish Registry of Esophagogastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00021320
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancertreatment2completed
NCT01929720
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT02166320
Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent.No drug interventionstreatment2completed
NCT05438420
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumorstreatment1 / 2recruiting
NCT01053182
Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet ApproachesNo drug interventionsprevention3unknown_status
NCT00096031
S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancertreatment2completed
NCT00573131
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancertreatment2terminated
NCT00197431
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancertreatment2unknown_status
NCT05725473
Clinical Efficacy and Safety of Endoscopic Dilatation With Eso-Filp in Benign Esophageal StricturesNo drug interventionstreatmentNot Availablerecruiting
NCT02729727
Clinical Study to Evaluate CryoBalloon™ Ablation System in Patients Undergoing EsophagectomyNo drug interventionsbasic_scienceNot Availablecompleted
NCT03734627
Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal SurgeryNot AvailableNot Availablecompleted
NCT00003427
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancertreatment1completed
NCT03492827
Evaluation of the Preventive Effect of Chlorhexidine Acetate Gargle for Upper Gastrointestinal Tract Infection After ESDpreventionNot Availableunknown_status
NCT01445327
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal CancersNo drug interventionsNot AvailableNot Availableterminated
NCT00682227
Peptide Vaccination in Treating Patients With Esophageal CancerNo drug interventionstreatment1unknown_status
NCT06068127
G-POEM for Refractory Gastroparesis After Esophagectomy With Gastric Pull-throughNo drug interventionsNot AvailableNot Availablerecruiting
NCT02323776
Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT06421376
Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal CancerNo drug interventionstreatment2recruiting
NCT00341276
Esophageal Cancer Genetics StudiesNo drug interventionsNot AvailableNot Availablecompleted
NCT01175460
S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancertreatment1completed
NCT01217060
Trimodality Management of T1b Esophageal Cancerstreatment1 / 2completed
NCT05523960
Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT01246960
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancertreatment2completed
NCT00011960
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgerytreatment2completed
NCT05192460
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06281860
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin AdministrationNo drug interventionstreatment1recruiting
NCT03165994
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancerstreatment2completed
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT01980394
Esophageal Stump WashoutNo drug interventionstreatmentNot Availablecompleted
NCT00520091
Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancertreatment2completed
NCT03482791
Proton Beam Therapy in the Treatment of Esophageal CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05855291
PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT02850991
Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal CarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT00544362
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgerytreatment1 / 2completed
NCT02556762
Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal CancerNo drug interventionstreatment3active_not_recruiting
NCT03223662
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision TherapyNo drug interventionstreatment2terminated
NCT00917462
Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancertreatment2completed
NCT00215462
Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinomatreatment2completed
NCT00316862
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgerytreatment2completed
NCT03799380
DRIHNC - Dehydration Reduction in Head & Neck CancerNo drug interventionssupportive_careNot Availablecompleted
NCT05281380
VITAMin Insufficiency in Esophagogastric NeoplasmsNo drug interventionstreatmentNot Availablerecruiting
NCT03176680
The Effects on Major Organ Complications on Esophagectomy of New Anesthetic ERAS Strategy: a Prospective InvestigationNo drug interventionstreatmentNot Availableunknown_status
NCT02744729
99mTc-3PRGD2 SPECT/CT in Esophagus Cancer PatientsNo drug interventionsdiagnostic0completed
NCT00368329
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancertreatment1terminated
NCT05547529
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal CancerNo drug interventionstreatment3recruiting
NCT06115629
Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) TrialNo drug interventionsdiagnostic3not_yet_recruiting
NCT00252889
Doxil Topotecan Doublet Cancer Studytreatment1completed
NCT01498289
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancertreatment2completed
NCT04316689
First-in-human Study of S-588210 (S-488210+S-488211)No drug interventionstreatment1completed
NCT00130689
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancertreatment2completed
NCT02829489
International Nutrition Audit in FORegut TuMorsNo drug interventionsNot AvailableNot Availablecompleted
NCT01512589
Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) TrialNo drug interventionstreatment2active_not_recruiting
NCT05698992
Rehabilitation and Recovery for Persons With Esophageal or Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00669292
PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancertreatment1 / 2unknown_status
NCT04400292
Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR ImagingNo drug interventionsdiagnosticNot Availablerecruiting
NCT05370144
A Study Involving Neoadjuvant Chemoradiotherapy With Hypofractionated Radiotherapy in Patients With Esophageal and Gastroesophageal Junction AdenocarcinomaNo drug interventionstreatmentNot Availablerecruiting
NCT00197444
Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancertreatment2completed
NCT00215644
Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancertreatment2completed
NCT05579444
Systems Biology of Gastrointestinal and Related DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT05182944
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCCNo drug interventionstreatment2recruiting
NCT02584244
Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersNo drug interventionsdiagnostic1 / 2recruiting
NCT05662644
Assessment of Minimally Invasive Surgery for Esophageal CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00790140
Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer SurgeryNo drug interventionstreatment4unknown_status
NCT03222440
Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCCtreatmentNot Availablecompleted
NCT06476067
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00004867
Positron Emission Tomography in Determining Stage of Esophageal CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)No drug interventionstreatmentNot Availablerecruiting
NCT02813967
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal CancerNo drug interventionstreatment3completed
NCT03066167
Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00896467
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT04674267
Resilience and Equity in Aging, Cancer, and Health (REACH)No drug interventionshealth_services_researchNot Availablerecruiting
NCT03205501
Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesionsdiagnostic1completed
NCT01463501
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal CancerNo drug interventionstreatment2unknown_status
NCT02318901
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancertreatment1 / 2terminated
NCT00534001
Bupropion in Helping Adults Stop Smokingother2completed
NCT04683601
Generation of a Surgical Field in the Left Lateral Decubitus PositionNo drug interventionsNot AvailableNot Availablecompleted
NCT03306901
Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell CarcinomatreatmentNot Availableactive_not_recruiting
NCT01555801
Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT04086901
Dose Escalated Adaptive RadioTherapy in Definitive Chemo-radiotherapy for Esophageal CancerNo drug interventionstreatmentNot Availableterminated
NCT00318604
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response MarkerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04871204
Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients With Esophageal or Gastric Cancertreatment2recruiting
NCT00397904
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatintreatment2completed
NCT00342472
Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian, ChinaNo drug interventionsNot AvailableNot Availablecompleted
NCT04077372
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal CancersNo drug interventionssupportive_careNot Availableterminated
NCT00757172
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junctiontreatment2completed
NCT00006472
Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancertreatment2terminated
NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumorsdiagnostic2recruiting
NCT06317272
BReath Hold TecHniquEs for Radiotherapy of Esophageal CarcinomaNo drug interventionstreatmentNot Availableterminated
NCT00393068
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancertreatment2completed
NCT05498168
Computational Prediction and Experimental Validation of Esophageal Cancer Associated NeoantigensNo drug interventionsNot AvailableNot Availableunknown_status
NCT05199168
Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves During Thoracoscopic EsophagectomyNo drug interventionstreatmentNot Availableunknown_status
NCT05048368
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic FunctionNo drug interventionstreatment1not_yet_recruiting
NCT01258868
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomastreatment1terminated
NCT04164069
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumabprevention1active_not_recruiting
NCT00256269
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinomatreatment2terminated
NCT00790569
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop SmokingpreventionNot Availablecompleted
NCT03378869
Perioperative Management and Outcomes of Minimally Invasive EsophagectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT06061146
Tislelizumab Plus Concurrent Chemoradiation in Older With ESCCtreatment2recruiting
NCT06430346
Exercise Prehabilitation for Locoregional Esophageal CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT00268346
Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancertreatment2completed
NCT00798746
Quality of Life After Esophagectomy for CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02311712
Non-endoscopic EC Screening Program in Northern IranNo drug interventionsscreeningNot Availableunknown_status
NCT00017212
DX-8951f in Treating Patients With Metastatic Stomach Cancertreatment2completed
NCT00711412
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancertreatment2completed
NCT00047112
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancertreatment3completed
NCT02547610
MR/PET in the Evaluation of Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05628610
Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancertreatment2not_yet_recruiting
NCT00019110
Vaccine Therapy in Treating Patients With Advanced or Recurrent CancerNo drug interventionstreatment1completed
NCT04804410
Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal TissuesNo drug interventionstreatmentNot Availableunknown_status
NCT03646110
The Comparison of Single and Multi-incision MIE for Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05049681
Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Celltreatment3unknown_status
NCT02803281
Assessment of Patient Frailty Prior to Thoracic SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02375581
Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancertreatment2unknown_status
NCT02324881
Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation TherapyNo drug interventionshealth_services_researchNot Availablecompleted
NCT00006081
Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancertreatment2completed
NCT00898495
Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT01033695
Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph NodesNo drug interventionsNot AvailableNot Availablecompleted
NCT05499195
Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic ResectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00522795
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)treatment2completed
NCT02938195
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal CancerNo drug interventionstreatment2unknown_status
NCT05538195
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT05553795
Drainless Robot-assisted Minimally Invasive EsophagectomyNo drug interventionstreatmentNot Availableterminated
NCT02292914
Prospective Analysis of Robot-Assisted SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT06464614
Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.treatment2not_yet_recruiting
NCT00757614
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomNo drug interventionsNot AvailableNot Availableunknown_status
NCT05462314
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal MalignanciesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04158414
Applying PET/MR in Oncology - a Prospective ProjectNo drug interventionsdiagnosticNot Availableunknown_status
NCT02864355
Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy PatientsNo drug interventionstreatmentNot Availableterminated
NCT02683655
Study of Apatinib in Metastatic Esophageal Cancertreatment2unknown_status
NCT00372450
Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignanciestreatment1completed
NCT00915850
Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)treatment1 / 2unknown_status
NCT00719550
AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancertreatment1 / 2completed
NCT00258323
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancertreatment2completed
NCT05376423
To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrencetreatment2recruiting
NCT04513808
Total Intravenous Anesthesia and Recurrence Free Survivaltreatment3recruiting
NCT04675138
Development of a Clinical Decision Support System With Artificial Intelligence for Cancer CareNo drug interventionsNot AvailableNot Availablerecruiting
NCT05187338
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumorstreatment1 / 2recruiting
NCT00006038
Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancertreatment2completed
NCT00737438
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinomatreatment2completed
NCT00005638
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancertreatment1completed
NCT06361043
Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)No drug interventionsNot AvailableNot Availablerecruiting
NCT01746043
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancertreatment2completed
NCT01904435
Cetuximab, Paclitaxel, Carboplatin And Radiation For Esophageal, Gastroesophageal Junction And Gastric Cancertreatment2completed
NCT01443065
MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinomatreatment2completed
NCT01032967
Surgery or Chemoradiation for Esophageal CancerNo drug interventionstreatment3completed
NCT06412419
Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00242723
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung LiningNo drug interventionsNot AvailableNot Availablerecruiting
NCT02335970
Effects of a Training Intervention After Thoracoabdominal Oesophagus SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT04151524
Classification of Adenocarcinoma of the Esophagogastric JunctionNo drug interventionsNot AvailableNot Availableunknown_status
NCT06048458
Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular PhenotypingNo drug interventionsNot AvailableNot Availablerecruiting
NCT02735057
Chemoradiotherapy in Elderly Patients With Oesophagus Cancertreatment1 / 2recruiting
NCT02260128
Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential NeedsNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT04776590
Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancertreatment2active_not_recruiting
NCT06278064
Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers DiagnosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03002064
Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patientstreatment3unknown_status
NCT02988921
MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing ChemoradiotherapydiagnosticNot Availablerecruiting
NCT05954702
Supercharged TRAM Evaluation in Cervical Esophagogastroplasty After EsophagectomyNo drug interventionstreatmentNot Availablerecruiting
NCT05390684
Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.No drug interventionsNot AvailableNot Availableunknown_status
NCT05780684
Individualized Dose Escalation of 5-FU for Gastrointestinal CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesNo drug interventionssupportive_careNot Availablerecruiting
NCT03332433
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by PropofolNo drug interventionspreventionNot Availablecompleted
NCT01774851
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomachtreatment2terminated
NCT05861947
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesNo drug interventionstreatment1recruiting
NCT06189898
Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00660205
Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02797405
Tumour and HEalthy Tissues DOse-response and Radiosensitivity AssayNo drug interventionsdiagnosticNot Availableterminated
NCT05898828
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancertreatment1 / 2withdrawn
NCT04821778
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancertreatment3recruiting
NCT03646409
Venous Thromboembolism and Bleeding Risk in Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05626309
Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04177875
Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancertreatment2unknown_status
NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SNo drug interventionstreatment1completed
NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesNo drug interventionstreatment1 / 2unknown_status
NCT02693236
DC Vaccine Combined With CIK Cells in Patients With Esophagus CancerNo drug interventionstreatment1 / 2unknown_status
NCT00193141
Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancertreatment2completed
NCT05174117
Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal CarcinomaNo drug interventionstreatmentNot Availableunknown_status
NCT06430658
Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancertreatment2recruiting
NCT06036563
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA SequencingNo drug interventionsNot AvailableNot Availablerecruiting
NCT03199586
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignanciestreatment1completed
NCT05829057
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1No drug interventionstreatment1recruiting
NCT06160557
A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03941626
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid MalignanciesNo drug interventionstreatment1 / 2unknown_status
NCT06043466
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapytreatment3completed
NCT05801666
Acupuncture Effect on Dumping Syndrome in Esophagus Cancer Patients With Feeding JejunostomyNo drug interventionssupportive_careNot Availablerecruiting
NCT04821765
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancertreatment2unknown_status
NCT02879227
Radiochemotherapy in Elderly Patients With Oesophagus Cancertreatment2completed
NCT04764227
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)treatment2active_not_recruiting
NCT05996276
Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION)No drug interventionsNot AvailableNot Availablerecruiting
NCT06010862
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT03070262
The Efficacy and Safety of Caffeic Acid for Esophageal CancerNo drug interventionstreatment3unknown_status
NCT03467529
Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05615129
Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant SettingNo drug interventionsNot AvailableNot Availablecompleted
NCT05602792
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT06092944
Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive EsophagectomyNo drug interventionstreatmentNot Availablerecruiting
NCT01626001
Imaging Study Compare 4DCT ImageNo drug interventionsdiagnostic1completed
NCT03298204
Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01No drug interventionsNot AvailableNot Availablecompleted
NCT02972372
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05569668
Neoadjuvant Chemotherapy Compared With Surgery for Esophageal CarcinomaNot AvailableNot Availablecompleted
NCT05637268
Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinomatreatment2recruiting
NCT03657914
Radical Resection of Single-hole Inflatable Mediastinal Mirror Synchronization With Laparoscopic Esophageal CarcinomaNo drug interventionstreatmentNot Availableunknown_status
NCT00593723
IMRT Tomotherapy for Esophagus CancerNo drug interventionstreatment1completed
NCT03269903
TTS Esophageal HILZO Stent: A Safety and Feasibility StudyNo drug interventionstreatmentNot Availableunknown_status
NCT04188990
Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related MalnutritionNo drug interventionstreatmentNot Availablecompleted
NCT02552121
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumorstreatment1 / 2completed
NCT03051802
Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and LungNo drug interventionsdevice_feasibilityNot Availableterminated
NCT04686747
COVID - 19 and Advanced Gastro-intestinal Cancer TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT05717998
Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00193128
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancertreatment1 / 2completed
NCT05023928
Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus CancerNo drug interventionstreatment1unknown_status
NCT01669356
The Effect of Parenteral Nutrition Supplement on Esophagectomy PatientsNo drug interventionstreatmentNot Availablecompleted
NCT06045715
Follow-up Strategy for Esophageal Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03342937
KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancertreatment2completed
NCT05807542
Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCCtreatment2completed
NCT06126406
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT01979549
Adverse Events During Upper Gastrointestinal EndoscopyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02216149
Effects of S-1 and Capecitabine on Coronary Artery Blood Flowtreatment2terminated
NCT03245736
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.treatment2completed
NCT03777813
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcertreatment2recruiting
NCT02436018
WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal EndoscopyNo drug interventionspreventionNot Availableunknown_status
NCT06385717
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06550063
HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03237130
Prediction of Lymphatic Metastasis in Esophageal Cancer by CT RadiomicsNo drug interventionsNot AvailableNot Availablecompleted
NCT03347630
Pre-operative MRI of Esophagus CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT05850130
Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT06143748
Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)treatment2recruiting
NCT02607826
Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid TumorsNo drug interventionssupportive_careNot Availableunknown_status
NCT00193882
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.treatment3completed
NCT02979691
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01No drug interventionstreatment2 / 3completed
NCT06147180
Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open EsophagectomyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04500392
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in ObesityNo drug interventionspreventionNot Availablerecruiting
NCT02961140
Different Anesthetic Managements of Esophageal Resection and ReconstructionNo drug interventionstreatmentNot Availableunknown_status
NCT01684904
Proton Therapy for Esophageal CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsNo drug interventionstreatment1 / 2active_not_recruiting
NCT02001623
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumorstreatment1 / 2completed
NCT06510543
Goal-directed Enteral Nutritional Perioperative ManagementNo drug interventionsotherNot Availablerecruiting